Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs Minerva Neurosciences, Inc (NERV)

LENZ Therapeutics, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. LENZ Therapeutics, Inc. and Minerva Neurosciences, Inc are of similar size ($115.6M and $112.2M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Minerva Neurosciences, Inc leads on 6 and LENZ Therapeutics, Inc. on 5.

Valuation

Metric LENZ NERV Biotechnology median
P/E n/m n/m 8.50
P/S 4.78 n/m 9.71
P/B 0.47 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.85 n/m 0.64
EV/Sales (5.36) n/m 9.21
Earnings yield (125.08%) (1,207.23%) (33.15%)
Free cash flow yield (111.53%) (24.00%) (25.50%)

Profitability

Metric LENZ NERV Biotechnology median
Gross margin 93.69% 0.00% 65.16%
Operating margin (631.70%) 0.00% 0.00%
Net margin (586.74%) 0.00% 0.00%
Free cash flow margin (532.80%) 0.00% 0.00%
Return on equity (59.21%) 322.05% (56.36%)
Return on assets (55.52%) (629.71%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LENZ NERV Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (21.79%) (18,347.37%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ NERV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 20.14 4.72
Net debt to EBITDA 3.22 5.46 0.96

Dividend

Metric LENZ NERV Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric LENZ NERV Biotechnology median
Market cap 112.17m 115.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack